Viatris Inc. to Present at the J.P. Morgan 39th Annual Healthcare Conference January 14, 2021 and Will Host its Inaugural Investor Day March 1, 2021
Viatris (NASDAQ: VTRS) will present at the J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Viatris (NASDAQ: VTRS) will present at the J.P. Morgan 39th Annual Healthcare Conference on January 14, 2021, at 7:30 a.m. ET, led by CEO Michael Goettler. Investors can listen live via the company's investor relations website. Additionally, Viatris will hold its inaugural Investor Day virtually on March 1, 2021, where leadership will discuss strategic plans and fiscal guidance for 2021. Webcasts for both events will be available live and archived at investor.viatris.com.
Details
News Market Reaction – VTRS
The recorded move for VTRS in the trading session of this news was +0.97%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PITTSBURGH, Dec. 10, 2020 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) will present at the J.P. Morgan 39th Annual Healthcare Conference on Thursday, January 14, 2021. Michael Goettler, chief executive officer, will make a formal presentation about the company at 7:30 a.m. ET.
Investors and the general public are invited to listen to a live webcast of the presentation at investor.viatris.com. An archived version also will be available following the live presentation and can be accessed at the same location for a limited time.
Viatris also announced that it will hold its inaugural Investor Day virtually on Monday, March 1, 2021. Several members of the leadership team will present a deep dive into the Company's strategy to deliver long-term value to shareholders, as well as details about Viatris' Global Healthcare Gateway™. Viatris also intends to initiate and discuss its financial guidance for fiscal year 2021.
Interested parties will be able to access a live webcast of the Investor Day event via the investor relations section of Viatris' website at investor.viatris.com, with materials available at the start of the webcast. A replay and archived edition of the presentation will be available following the event.
About Viatris
Viatris Inc. (NASDAQ: VTRS) is a new kind of healthcare company, empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway™. Formed in November 2020 through the combination of Mylan and Pfizer's Upjohn business, Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris' portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized brands, complex generic and branded medicines, a growing portfolio of biosimilars and a variety of over-the-counter consumer products. With a global workforce of approximately 45,000, Viatris is headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on Twitter at @ViatrisInc, LinkedIn and YouTube.
View original content to download multimedia:http://www.prnewswire.com/news-releases/viatris-inc-to-present-at-the-jp-morgan-39th-annual-healthcare-conference-january-14-2021-and-will-host-its-inaugural-investor-day-march-1-2021-301190287.html
SOURCE Viatris Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.